Results of studies of drug-resistant breast cancer cell lines showed that transfection with miR-505 induced apoptosis by targeting alternative splicing factor/splicing factor 2 (ASF/SF2) [51]. The gene discussed is SRSF1; the disease is breast carcinoma.